---
title: "Xizang Weixinkang Pharmaceutical: Elected Daniel Zhang as Chairman"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238297799.md"
description: "On the evening of April 30th, Xizang Weixinkang Pharmaceutical announced that the board of directors meeting agreed to elect Daniel Zhang as the chairman of the company's fourth board of directors and to elect Liu Feng as the vice chairman of the company's fourth board of directors, with terms consistent with the term of the company's fourth board of directors"
datetime: "2025-04-30T13:04:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238297799.md)
  - [en](https://longbridge.com/en/news/238297799.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238297799.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical: Elected Daniel Zhang as Chairman

On the evening of April 30th, Xizang Weixinkang Pharmaceutical announced that the board of directors meeting agreed to elect Daniel Zhang as the chairman of the fourth board of directors of the company and to elect Liu Feng as the vice chairman of the fourth board of directors of the company, with terms consistent with the term of the fourth board of directors of the company

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [Bank of Communications schedules interim results webcast briefing](https://longbridge.com/en/news/296324060.md)
- [Michaels launches omnichannel custom framing experience with Architectural Digest](https://longbridge.com/en/news/296643293.md)
- [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md)
- [SandboxAQ introduces AQPotency for virtual drug screening](https://longbridge.com/en/news/296467103.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**